Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

[1]  R. Rouzier,et al.  The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) database , 2010, BJOG : an international journal of obstetrics and gynaecology.

[2]  A. Reuss,et al.  Potential role of lymphadenectomy in advanced ovarian cancer: a combined exploratory analysis of three prospectively randomized phase III multicenter trials. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  D. Levine,et al.  Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. , 2009, Gynecologic oncology.

[4]  Jacobus Pfisterer,et al.  Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials , 2009, Cancer.

[5]  R. Bristow,et al.  Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer. , 2008, Gynecologic oncology.

[6]  R. Ozols,et al.  Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  D. Levine,et al.  The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer. , 2006, Gynecologic oncology.

[8]  A. Çiçekcibaşı,et al.  A rare variation of the coeliac trunk. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[9]  D. Levine,et al.  Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach. , 2004, Gynecologic oncology.

[10]  R. Rouzier,et al.  Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. , 2003, Journal of the American College of Surgeons.

[11]  N. Spirtos,et al.  Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study. , 2003, Gynecologic oncology.

[12]  S. Tangjitgamol,et al.  Can we rely on the size of the lymph node in determining nodal metastasis in ovarian carcinoma? , 2003, International Journal of Gynecologic Cancer.

[13]  V. Gebski,et al.  Secondary Cytoreductive Surgery for Recurrent Epithelial Ovarian Cancer , 2002, Obstetrics and gynecology.

[14]  E. Trimble,et al.  Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  N. Spirtos,et al.  What are the current surgical objectives, strategies, and technical capabilities of gynecologic oncologists treating advanced epithelial ovarian cancer? , 2001, Gynecologic oncology.

[16]  J. Fiorica,et al.  Accuracy of Lymph Node Palpation to Determine Need for Lymphadenectomy in Gynecologic Malignancies , 2000, Obstetrics and gynecology.

[17]  Y. Taketani,et al.  Assessment of metastases to aortic and pelvic lymph nodes in epithelial ovarian carcinoma: A proposal for essential sites for lymph node biopsy , 1996, Cancer.

[18]  G. Scambia,et al.  Anatomical and pathological study of retroperitoneal nodes in epithelial ovarian cancer. , 1993, Gynecologic oncology.

[19]  J. Siewert,et al.  Radical surgical procedure improves survival time in patients with recurrent ovarian cancer , 1992, Cancer.

[20]  Huayue Chen,et al.  Anatomic variation of the celiac trunk with special reference to hepatic artery patterns. , 2009, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[21]  N. Spirtos,et al.  The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma , 2000, Cancer.

[22]  P. Sugarbaker,et al.  Peritoneal Carcinomatosis: Principles of Management , 1996, Cancer Treatment and Research.